Vivanza Bio Board met: Approved FY25-26 reports and the 44th AGM.

VB

Vivanza Biosciences Ltd530057 · Filed with the exchange

Shareholders will consider new MoA/AoA, higher borrowing limits, and significant related party transactions/financial dealings. #VivanzaBio

No comments yet. Be the first.

More from Vivanza Biosciences Ltd

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.